TherapeuticsMD | TXMD - Ativo Circulante





Ativo Circulante Alterar Data
AbbVie USD 37.48B 3.81B 2026-09
Alterity Therapeutics Limited AUD 37.91M 15.92M 2025-12
Cipla INR 250.61B 9.14B 2026-09
Clal Biotechnology ILS 14.69M 1.95M 2023-12
Compugen USD 129.41M 7.88M 2026-06
CSL USD 11.85B 1000K 2025-12
Grifols EUR 5.96B 316.31M 2025-12
Novo Nordisk DKK 31.89B 145.42B 2026-06
Pfizer USD 45.01B 3.65B 2026-09
TherapeuticsMD USD 11.82M 303K 2024-06